A critical reflection on our first patient presenting with Anti-Nmethyl- D-aspartate receptor encephalitis
One of the best characterized autoimmune encephalitis is the Anti-Nmethyl-D-aspartate receptor (NMDAR) encephalitis, which may occur in the presence of cancer. First- and second-line immunotherapy and oncological investigations are suggested. We present here a case of an 18-year-old female who was...
Main Authors: | Susanne Buechner, Igor Florio, Gabriele J. Sixt, Francesco Teatini |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | Neurology International |
Subjects: | |
Online Access: | https://www.pagepress.org/journals/index.php/ni/article/view/8253 |
Similar Items
-
Combined Therapy for Anti-N-methyl D-aspartate Receptor Encephalitis
by: Takahiro Kido, et al.
Published: (2017-09-01) -
Anti-N-methyl-D-aspartate receptor encephalitis presenting as atypical psychosis in multiple sclerosis: a case report
by: Khushminder Chahal, et al.
Published: (2021-07-01) -
Anti-N-Methyl-d-Aspartate receptor (NMDAR) encephalitis during pregnancy: Clinical analysis of reported cases
by: Yan-Chao Shi, et al.
Published: (2017-06-01) -
Spectrum of anti-NMDA receptor antibody encephalitis: Clinical profile, management and outcomes
by: Amlan Kusum Datta, et al.
Published: (2021-01-01) -
Anti-<it>N</it>-methyl-D-aspartate receptor encephalitis presenting with acute psychosis in a preteenage girl: a case report
by: Maggina Paraskevi, et al.
Published: (2012-07-01)